1. Remdesivir in COVID-19: a critical review of pharmacology, pre-clinical and clinical studies;Singh;Diabetes Metab Syndr,2020
2. 2. Fischer W, Eron JJ, Holman W, et al. Molnupiravir, an oral antiviral treatment for COVID-19. medRxiv [Preprint].
3. 3. Veklury. US FDA approved product information; Foster City, CA: Bristol Gilead Sciences, Inc; October 2020. Accessed November 22, 2022. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf
4. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis;Angamo;Infection,2022
5. 5. Agarwal A, Hunt B, Stegemann M, et al. A living WHO guideline on drugs for COVID-19. BMJ 2020;370:m3379. Update in: BMJ. 2020;371:m4475. Update in: BMJ 2021;372:n860. Update in: BMJ 2021;374:n1703. Update in: BMJ 2021;374:n2219. Erratum in: BMJ 2022;377:o1045.